Sevelamer HCl, a non-aluminum, non-calcium containing hydrogel, has proved an effective phosphate binder in North American hemodialysis patients. This single-center, open-label, dose titration study assessed the efficacy of sevelamer in a cohort of European hemodialysis patients with different dietary habits, in particular with lower phosphate intake. The aim of the study was to obtain a calcium x phosphate product lower than 60 mg2/dL2 in all patients.
Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients / M. Gallieni, M. Cozzolino, P. Carpani, U. Zoni, D. Brancaccio. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - 14:3(2001), pp. 176-183.
Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients
M. GallieniPrimo
;M. CozzolinoSecondo
;U.G. ZoniPenultimo
;D. BrancaccioUltimo
2001
Abstract
Sevelamer HCl, a non-aluminum, non-calcium containing hydrogel, has proved an effective phosphate binder in North American hemodialysis patients. This single-center, open-label, dose titration study assessed the efficacy of sevelamer in a cohort of European hemodialysis patients with different dietary habits, in particular with lower phosphate intake. The aim of the study was to obtain a calcium x phosphate product lower than 60 mg2/dL2 in all patients.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
